Rituximab: Recommendations of the French Vasculitis Study Group (FVSG) for induction and maintenance treatments of adult, antineutrophil cytoplasm antibody-associated necrotizing vasculitides. [electronic resource]
Producer: 20131223Description: 1317-30 p. digitalISSN:- 2213-0276
- Adult
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis -- therapy
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Education, Medical, Continuing
- France
- Humans
- Immunosuppressive Agents -- therapeutic use
- Immunotherapy -- legislation & jurisprudence
- Induction Chemotherapy -- methods
- Maintenance Chemotherapy -- methods
- Prospective Studies
- Rituximab
- Societies, Medical -- legislation & jurisprudence
- Surveys and Questionnaires
- Vasculitis -- etiology
No physical items for this record
Publication Type: Journal Article; Practice Guideline
There are no comments on this title.
Log in to your account to post a comment.